
    Original Text: Had radiotherapy within 3 weeks prior to Cycle 1 Day 1 (cycle is 28 days)
    Disease/Condition: none
    Procedure: Radiotherapy
    Drug: none
    Biomarker: none
    Computable Rule: "Had radiotherapy within 3 weeks prior to Cycle 1 Day 1 (cycle is 28 days)" is True

Criterion:
    Subjects with metastatic breast cancer who had received no more than one chemotherapy regimen for metastatic disease, including adjuvant therapy, and whose tumors were positive for HER-2/neu overexpression by immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH), or both, and who had progressed on trastuzumab-based therapy

Output:
    Original Text: Subjects with metastatic breast cancer who had received no more than one chemotherapy regimen for metastatic disease, including adjuvant therapy, and whose tumors were positive for HER-2/ne